Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: A dietary intervention trial with fifty healthy post-menopausal Caucasian women

British Journal of Nutrition

Volumn 98, Issue 5, 2007, Pages 950-959

  Bolca, Selin ^a   Possemiers, Sam ^a   Maervoet, Veerle ^a   Huybrechts, Inge ^b   Heyerick, Arne ^a   Vervarcke, Stefaan ^c   Depypere, Herman ^b   De Keukeleire, Denis ^a   Bracke, Marc ^b   De Henauw, Stefaan ^b   Verstraete, Willy ^a   Van de Wiele, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Biodynamics bvba   (Belgium)

Author keywords

8 Prenylnaringenin; Hops; Phyto oestrogens; Post menopausal women

Indexed keywords

8 PRENYLNARINGENIN; ANTIBIOTIC AGENT; CAFFEINE; FLAVONOID; METHANE; NARINGENIN; PHYTOESTROGEN; THEOBROMINE; UNCLASSIFIED DRUG; XANTHOHUMOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; ARTICLE; BREATH ANALYSIS; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMETHYLATION; DIET THERAPY; ESTROGEN ACTIVITY; FAT INTAKE; FECES ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MICROBIAL METABOLISM; NORMAL HUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PLANT FIBER; POSTMENOPAUSE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; TEST MEAL; URINALYSIS; URINARY EXCRETION;

AGED; ANTI-BACTERIAL AGENTS; DIET; DIETARY SUPPLEMENTS; FECES; FEMALE; FLAVANONES; GASTROINTESTINAL TRACT; HUMANS; HUMULUS; METHANE; MIDDLE AGED; PHENOTYPE; PHYTOESTROGENS; POSTMENOPAUSE; PROPIOPHENONES; XANTHONES;

HUMULUS;

EID: 35148830351     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507749243     Document Type: Article

References (50)

1. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3, 364-373.
2. Fletcher RJ (2003) Food sources of phyto-oestrogens and their precursors in Europe. Br J Nutr 89, S39-S43.
3. Ososki AL & Kennely EJ (2003) Phytoestrogens: A review of the present state of research. Phytother Res 17, 845-869.
4. Rowland IR, Faughnan M, Hoey L, W & Wähälä K, Williamson G & Cassidy A (2003) Bioavailability of phyto-estrogens. Br J Nutr 89, S45-S58.
5. Blakesmith SJ, Lyons-Wall PM, Joannou GE, Petocz P & Samman S (2005) Urinary isoflavonoid excretion is inversely associated with the ratio of protein to dietary fibre intake in young women. Eur J Nutr 59 284-290.
6. Horner NK, Kristal AR, Prunty J, Skor HE, Potter JD & Lampe JW (2002) Dietary determinants of plasma enterolactone. Cancer Epidemiol Biomarkers Prev 11, 121-126.
7. Coldham NG & Sauer MJ (2001) Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem Toxicol 39, 1211-1224.
8. Heyerick A, Vervarcke S, Depypere HT, Bracke ME & De Keukeleire D (2006) A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54, 164-175.
9. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L & De Keukeleire D (1999) Identification of a potent phytoestrogen in hops (Humudus lupulus L.) and beer. J Clin Endocrinol Metab 83, 2249-2252.
10. Schaefer O, Hümpel M, Fritzemeier K-H, Bohlmann R & Schleuning W-D (2003) 8-prenylnaringenin is a potent ERα selective phytoestrogen present in hops and beer. J Steroid Biochem Mol Biol 84, 359-360.
11. Possemiers S, Heyerick A, Robbens V, De Keukeleire D & Verstraete W (2005) Activation of pro-estrogens form hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 53, 6281-6288.
12. Guo J, Nikolic D, Chadwick LR, Pauli GF & van Breemen RB (2006) Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol form hops (Humulus lupulus L.). Drug Metab Dispos 34, 1152-1159.
13. Nikolic D, Li Y, Chadwick LR, Grubjesic S, Schwab P, Metz P & van Breemen RB (2004) Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus), by human liver microsomes. Drug Metab Dispos 32, 272-279.
14. Stevens JF, Taylor AW & Deinzer ML (1999) Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr A 832, 97-107.
15. Possemiers S, Bolca S, Grootaert C, Heyerick A, Decroos K, Dhooge W, De Keukeleire D, Rabot S, Verstraete W & Van de Wiele T (2006) Isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136, 1862-1867.
16. Schaefer O, Bohlmann R, Schleuning W-D, Schulze-Forster K & Hümpel M (2005) Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J Agric Food Chem 53, 2881-2889.
17. Rowland IR, Wiseman H, Sanders TAB, Adlercreutz H & Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27-32.
18. Cummings JH & Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70 443-459.
19. Frankenfeld CL, Patterson RE, Homer NK, Neuhouser ML, Skor HE, Kalhorn TF, Howald WN & Lampe JW (2003) Validation of a soy food frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr 77, 674-680.
20. Soares ACF, Lederman HM, Fagundes-Neto U & de Morais MB (2005) Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 39, 512-515.
21. Boeckx P, Van Cleemput O & Villaralvo I (1996) Methane emission from a landfill and the methane oxidising capacity of its covering soil. Soil Biol Biochem 28, 1397-1405.
22. Hoey L, Rowland IR, Lloyd AS, Clarke DB & Wiseman H (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 91 607-616.
23. Berg JO, Nord CE & Wadstrom T (1978) Formation of glycosidases in batch and continuous cultures of Bacteroides fragilis. Appl Environ Microbiol 35, 269-273.
24. Superior Health Council (2006) Recommended daily allowances in Belgium: Revisions November. 2006, 1st ed. Brussels: Federal Public Service Health, Food Chain Safety Environment.
25. Frankenfeld CL, McTiernan A, Tworoger SS, et al. (2004) Serum steroid hormones, sex hormone-binding globulin concentrations and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes, J Steroid Biochem Mol Biol. 88, 399-408.
26. Pollock BG, Wylie M & Stack JA (1999) Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 39, 936-940.
27. Avula B, Ganzera M, Warnick JE, Feltenstein MW, Sufka KJ & Khan IA (2004) High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine and fecal samples. J Chromatogr Sci 42, 378-482.
28. Gerhaüser C, Alt A, Heiss E, et al. (2002) Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol Cancer Ther. 11 959-969.
29. Nikolic D, Li Y, Chadwick LR & van Breemen RB. (2006) In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen form hops (Humulus lupulus L.). Pharm Res 23, 864-872.
30. Rad M, Hümpel M, Schoemaker RC, Schleuning W-D, Cohen AE & Burggraaf J (2006) Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol 62, 288-296.
31. Setchell KDR, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B. Jakate AS, Creutzinger V & Heubi JE (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027-1035.
32. Wiseman H, Casey K, Bowey EA, Duffy R. Davies M, Rowland IR. Lloyd AS, Murray A, Thompson A & Clarke DB (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80, 692-699.
33. Xu X, Wang H, Murphy PA, Cook L & Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832.
34. Karr SC, Lampe JW, Huchins AM & Slavin JL (1997) Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46-51.
35. Lampe JW, Karr SC, Hutchins AM & Slavin JL (1998) Urinary equol excretion with a soy challenge: Influence of habitual diet. Proc Soc Exp Biol Med 217, 335-339.
36. Bond JH, Engel RR & Levitt MD (1971) Factors influencing pulmonary methane excretion in man. J Exp Med 133, 572-588.
37. Miller TL & Wolin MJ (1986) Methanogens in human and animal intestinal tracts. Syst Appl Microbiol 7(2-3), 223-229.
38. Fernandes J, Wolever TMS & Rao AV (2000) Interrelationships between age, total dietary fiber intake and breath methane in humans. Nutr Res 20, 929-940.
39. Calloway DH, Colasito DJ & Mathews RD (1966) Gases produced by human intestinal microflora. Nature 212, 1238-1239.
40. Frankenfeld CL, Atkinson C, Thomas WK, Goode EL, Gonzalez A, Jokela T, Wähälä K, Schwartz SM, Li SS & Lampe JW (2004) Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med, 229, 902-913.
41. LeMarchand L, Franke AA, Custer LJ, Wilkens LR & Cooney RV (1997) Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7, 11-19.
42. Rizzo N, Hispard E, Dolbeault S, Dally S, Leverge R & Girre C (1997) Impact of long-term ethanol consumption on CYP1A2 activity. Clin Pharmacol Ther 62, 505-509.
43. Higdon JV & Frei B (2006) Coffee and health: A review of recent human research. Crit Rev Food Sci Nutr 46, 101-123.
44. Gates S & Miners O (1999) Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. J Clin Pharmacol 47, 299-305.
45. Lampe JW, Sker HE, Wähälä K, Howald WN & Chen C (2001 Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131, 740-744.
46. Vedrine N, Mathey J, Morand C, Brandolini M, Davicco MJ, Guy L, Remesy C, Coxam V & Manach C (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60, 1039-1045.
47. 14C]biochanin A in sheep. Aust J Agric Res 22, 131-138.
48. Lundh TJO, Pettersen H & Kiessling K (1988) Demethylation and conjugation of formononetin and daidzein in sheep, and cow liver microsomes. J Agric Food Chem 36, 22-25.
49. Schmider J, Greenblatt DJ, Von Moltke LL, Karsov D, Vena R, Friedman HL & Shader RI (1997) Biotransformation of mestranol to ethinyl estradiol in vitro: The role of cytochrome P-450 2C9 and metabolic inhibitor. J Clin Pharmacol 37, 193-200.
50. Milligan SR, Kalita JC, Pocock V, Heyerick A, De Cooman L, Rong H & De Keukeleire D (2002) Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123, 235-242.